Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Interest Coverage Ratio (2016 - 2017)

Corcept Therapeutics' Interest Coverage Ratio history spans 2 years, with the latest figure at 130.56 for Q2 2017.

  • For Q2 2017, Interest Coverage Ratio rose 4497.35% year-over-year to 130.56; the TTM value through Mar 2018 reached 705.2, up 857.41%, while the annual FY2011 figure was 1293.28, 17.84% down from the prior year.
  • Interest Coverage Ratio for Q2 2017 was 130.56 at Corcept Therapeutics, up from 2.84 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 130.56 in Q2 2017 and bottomed at 2.84 in Q2 2016.